Nora D. Volkow, M.D.
Director, National Institute on Drug Abuse (NIDA)
Director of NIDA since 2003 whose brain-imaging research on addiction transformed how medicine views substance use disorders — and whose evolving stance on psychedelic research has been pivotal for federal funding and regulatory support.
Biography
Nora D. Volkow is a psychiatrist and neuroscientist who has directed the National Institute on Drug Abuse since 2003, making her one of the most powerful figures in determining which drug-related research the federal government funds and supports. She is a great-granddaughter of Leon Trotsky and trained in psychiatry and nuclear medicine in Mexico before building a research career at Brookhaven National Laboratory focused on brain imaging and the neuroscience of addiction.
Volkow's foundational research using PET imaging demonstrated that addiction is a brain disease — showing that the brains of people with addiction have measurable structural and functional differences in dopaminergic circuits governing reward, motivation, and impulse control. This work shifted mainstream medicine's framing of addiction from moral failure to medical condition, laying the foundation for treating substance use disorders with the same empirical rigor as other medical conditions.
As NIDA director, Volkow has historically been conservative on psychedelic research, reflecting the federal research establishment's long-standing caution. However, as the evidence base from Hopkins, NYU, Imperial, and other institutions grew through the 2010s, her position evolved. NIDA has increasingly funded psychedelic research, and Volkow has publicly acknowledged psilocybin's therapeutic potential, particularly for addiction — an application directly within NIDA's core mission.
Her institutional imprimatur matters enormously: when NIDA signals openness to a research area, study sections change, grant applications get funded, and academic medical centers feel comfortable building programs. The psychedelic research renaissance owes some of its institutional normalization to her evolving position.
Organizations
Why They Matter to the LearnShrooms Community
NIDA controls hundreds of millions of dollars in addiction research funding. As the federal government's most authoritative voice on addiction, Volkow's evolution from skepticism to cautious support for psychedelic research has opened doors that were previously closed — enabling academic medical centers to invest in psychedelic programs without fear of jeopardizing their broader NIH funding relationships.
Legal Context
For the legal landscape where Nora D. Volkow, M.D. operates, see psilocybin laws in Maryland.